PathAI, Bristol Meyers Squibb: Evolving strategic relationship will drive the use of artificial intelligence (AI)-powered pathology in translational research and clinical trials BOSTON — August 25, 2022 — PathAI, a global leader in...

Deep Bio: Demonstrated globally-recognized standards in safety and quality management as a medical software manufacturer SEOUL, SOUTH KOREA (PRWEB) AUGUST 16, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced...

While it's long been understood that predicting outcomes in patients with cancer requires considering many factors, such as patient history, genes and disease pathology, clinicians struggle with integrating this information to make decisions...

Lumea, a leader in digital pathology solutions, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions LEHI, UTAH, UNITED STATES, August 4, 2022 /EINPresswire.com/ -- Lumea Inc, a leader...

July 28, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), for patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis (DBT), biopsy of all areas may be warranted, given...

Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics The VENTANA DP 600 is Roche’s new, high-capacity slide scanner that creates high-resolution, digital images of...